Status:
UNKNOWN
Ocular Imaging Study Using Advanced OCT
Lead Sponsor:
University of California, Los Angeles
Conditions:
Retinal Vascular Disorder
Macular Degeneration
Eligibility:
All Genders
18-115 years
Brief Summary
The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera,...
Eligibility Criteria
Inclusion
- • Any patient with abnormal retinal findings as determined by investigators.
Exclusion
- Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging.
- Participants who are unable to maintain retinal fixation on a specified target.
- Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place.
- Patients with media opacity which preclude high quality imaging.
Key Trial Info
Start Date :
July 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT02827071
Start Date
July 1 2016
Last Update
July 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stein Eye Institute/Geffen School of Medicine
Los Angeles, California, United States, 90095